Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Irhythm Technologies (0A7L) Share Price & Analysis

0 Followers

0A7L Stock Chart & Stats

$87.97$4.12(4.92%)
At close: 4:30 PM GMT
$80$100$120Aug 17Sep 1Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$84.20 - $89.52
52-Week Range
$83.47 - $191.13
Previous Close
$83.85
Volume
N/A
Average Volume (3M)
177
Market Cap
$2.89B
Enterprise Value
$3.92B
Total Cash (Recent Filing)
$560.72M
Total Debt (Recent Filing)
$725.73M
Price to Earnings (P/E)
―
Beta
0.84
Next Earnings
Feb 25, 2027 (Est.)
EPS Estimate
0.16
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth And Margins

Revenue has expanded from $323 million in 2021 to $854 million on a TTM basis while gross margins remain strong. This combination indicates meaningful scale, sustained demand for the monitoring platform, and operating potential that can support further investment and profit improvement.

Expanded Cardiac Monitoring Portfolio

The VitalConnect acquisition broadens iRhythm beyond its core monitoring products into mobile telemetry, multi-vital sensing, and hospital-to-home workflows. A wider product portfolio can increase addressable market coverage, deepen provider relationships, and create more cross-selling opportunities over time.

Differentiated Clinical Evidence

Large-scale clinical evidence supporting diagnostic performance and lower downstream healthcare utilization strengthens the credibility of Zio with clinicians and payors. This evidence can support durable adoption, reinforce differentiation from competing platforms, and improve access to monitoring opportunities.

Bears Say

High Balance-Sheet Leverage

Debt substantially exceeds the equity base, leaving iRhythm with limited balance-sheet flexibility relative to its obligations. High leverage can constrain investment choices, increase sensitivity to operating setbacks, and make future financing or refinancing more important to sustaining growth.

GAAP Profitability Not Yet Durable

Despite improving losses and strong gross margins, iRhythm has not yet established recurring GAAP profitability. Continued net losses reduce internally generated capital, leave earnings more dependent on execution improvements, and make the long-term durability of its operating model less proven.

Regulatory And Market-Access Execution Risk

Delayed regulatory submission for next-generation Zio MCT could postpone product expansion, while ongoing DOJ dialogue and a pending FDA follow-up inspection create continuing execution uncertainty. These matters may affect launch timing, oversight burden, and market access over the next several quarters.

Irhythm Technologies News

0A7L FAQ

What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest share price was $83.47 and its highest was $191.13 in the past 12 months.
What is Irhythm Technologies’s market cap?
Irhythm Technologies’s market cap is $2.89B.
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s next earnings report is estimated for Feb 25, 2027 (not yet confirmed), which is in 105 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Nov 05, 2026. The company reported -$0.9 earnings per share for the quarter, missing the consensus estimate of $0.015 by -$0.915.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is 0.16.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 33,618,145 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$0.9 in its last earnings report, missing expectations of $0.015. Following the earnings report the stock price went down -29.672%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Hedge funds hold Irhythm Technologies shares: the largest hedge-fund position in Irhythm Technologies is 541,271,995 shares, and hedge funds decreased their holdings by 2.0M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology